HeartMate II helps 75% transplant patients
This article was originally published in Clinica
Executive Summary
A new trial has indicated that the HeartMate II, Thoratec's next-generation left ventricular assist device (LVAD), is of use in prolonging the lives of heart-failure patients awaiting transplants.